HK1208498A1 - Method and composition for preventing stem cell disruption and aggregation - Google Patents

Method and composition for preventing stem cell disruption and aggregation

Info

Publication number
HK1208498A1
HK1208498A1 HK15109256.3A HK15109256A HK1208498A1 HK 1208498 A1 HK1208498 A1 HK 1208498A1 HK 15109256 A HK15109256 A HK 15109256A HK 1208498 A1 HK1208498 A1 HK 1208498A1
Authority
HK
Hong Kong
Prior art keywords
aggregation
composition
stem cell
cell disruption
preventing stem
Prior art date
Application number
HK15109256.3A
Other languages
English (en)
Chinese (zh)
Inventor
羅廷燦
姜成根
申燮
Original Assignee
Stemcell Co Ltd K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stemcell Co Ltd K filed Critical Stemcell Co Ltd K
Publication of HK1208498A1 publication Critical patent/HK1208498A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/71—Oxidoreductases (EC 1.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
HK15109256.3A 2012-04-13 2015-09-21 Method and composition for preventing stem cell disruption and aggregation HK1208498A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20120038828 2012-04-13
PCT/KR2013/003141 WO2013154404A1 (fr) 2012-04-13 2013-04-15 Procédé et composition pour la prévention de la dégradation et de l'agrégation de cellules souches

Publications (1)

Publication Number Publication Date
HK1208498A1 true HK1208498A1 (en) 2016-03-04

Family

ID=49327896

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15109256.3A HK1208498A1 (en) 2012-04-13 2015-09-21 Method and composition for preventing stem cell disruption and aggregation

Country Status (10)

Country Link
US (1) US9433645B2 (fr)
EP (1) EP2837682B1 (fr)
JP (1) JP5931277B2 (fr)
KR (1) KR101467481B1 (fr)
CN (1) CN104755609B (fr)
AU (1) AU2013247455A1 (fr)
HK (1) HK1208498A1 (fr)
MX (1) MX359002B (fr)
WO (1) WO2013154404A1 (fr)
ZA (1) ZA201407412B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104520423B (zh) 2012-04-18 2017-07-04 K-干细胞有限公司 用于生产具有适于血管内给药的尺寸的干细胞的方法
KR101583569B1 (ko) * 2013-05-15 2016-01-08 라정찬 정맥 투여용 줄기세포 조성물
CA2974620C (fr) * 2015-01-29 2021-06-22 The University Of Tokyo Procede de culture cellulaire, agregats cellulaires, agent de regulation de l'agregation cellulaire et milieu
KR101648915B1 (ko) 2016-05-16 2016-08-17 주식회사 디지레이 줄기세포의 응집방지 방법 및 그 조성물
US11788061B2 (en) 2016-07-29 2023-10-17 Jeong Chan Ra Method for producing mesenchymal stem cells that inhibit proliferation of cancer cells
CN109689855B (zh) * 2016-12-27 2021-10-26 富有干细胞株式会社 从三维多孔支架回收培养细胞的方法
WO2018186421A1 (fr) * 2017-04-03 2018-10-11 株式会社カネカ Population cellulaire comprenant des cellules souches mésenchymateuses, son procédé de production, et composition pharmaceutique
TWI704923B (zh) * 2017-06-26 2020-09-21 台灣基督長老教會馬偕醫療財團法人馬偕紀念醫院 包含胞外囊泡之製劑、用以製備該製劑之方法及其用途
CN109423476A (zh) * 2017-08-21 2019-03-05 青岛瑞思德生物科技有限公司 用于制备脂肪间充质干细胞的试剂盒
KR102233568B1 (ko) * 2019-12-13 2021-03-30 주식회사 알바이오 항암 바이러스가 도입된 중간엽 줄기세포의 세포 생존능을 향상시키는 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2308963A3 (fr) 2001-12-07 2011-09-21 Cytori Therapeutics, Inc. Systèmes pour le traitement des cellules obtenues par liposuccion
MXPA05009044A (es) * 2003-02-20 2006-03-17 Macropore Biosurgery Inc Metodos para utilizar celulas derivadas de tejido adiposo en el tratamiento de condiciones cardiovasculares.
WO2005011569A2 (fr) * 2003-06-18 2005-02-10 Macropore Biosurgery Inc. Methodes comprenant l'utilisation de cellules derivees du tissu adipeux pour le transfert de graisse autologue a des fins d'augmentation
ES2527293T3 (es) 2004-08-16 2015-01-22 Cellresearch Corporation Pte Ltd Aislamiento de células madre/progenitoras de membrana amniótica del cordón umbilical
KR100818214B1 (ko) 2006-09-29 2008-04-01 재단법인서울대학교산학협력재단 인간 태반조직의 양막 또는 탈락막 유래 다분화능 줄기세포및 그 제조방법
KR100795708B1 (ko) 2006-12-26 2008-01-17 주식회사 알앤엘바이오 인간 양막 상피세포 유래 성체 줄기세포의 분리 및 배양방법
ES2325715B1 (es) * 2007-08-03 2010-06-17 Genetrix, S.L. Poblacion de celulas madre adultas derivadas de tejido adiposo cardiaco y su uso en regeneracion cardiaca.
US20120122816A1 (en) * 2009-02-05 2012-05-17 Resolvyx Pharmaceuticals, Inc. Compositions and methods for organ preservation
US20120263685A1 (en) * 2009-10-08 2012-10-18 Rnl Bio Co., Ltd Anti-tumor composition comprising human-derived adult stem cells
US20120020931A1 (en) * 2010-06-02 2012-01-26 Rutgers, The State University Of New Jersey Therapeutic encapsulated embryonic stem cells and mesenchymal stromal cells
CN103502437B (zh) * 2010-07-20 2016-08-03 南加州大学 高端粒酶活性的骨髓间充质干细胞、其制造方法和基于其的药物和治疗方法
KR101293637B1 (ko) * 2011-01-14 2013-08-13 서울대학교병원 줄기세포의 부유배양용 조성물

Also Published As

Publication number Publication date
EP2837682B1 (fr) 2017-09-20
KR20130116213A (ko) 2013-10-23
CN104755609A (zh) 2015-07-01
JP2015513918A (ja) 2015-05-18
WO2013154404A1 (fr) 2013-10-17
KR101467481B1 (ko) 2014-12-01
EP2837682A4 (fr) 2015-09-02
ZA201407412B (en) 2016-09-28
EP2837682A1 (fr) 2015-02-18
CN104755609B (zh) 2017-09-05
US20150118194A1 (en) 2015-04-30
AU2013247455A1 (en) 2014-11-20
MX359002B (es) 2018-09-12
US9433645B2 (en) 2016-09-06
MX2014012260A (es) 2015-07-14
JP5931277B2 (ja) 2016-06-08

Similar Documents

Publication Publication Date Title
HK1208498A1 (en) Method and composition for preventing stem cell disruption and aggregation
EP2908629A4 (fr) Compositions et procédés de recrutement et de localisation de cellules souches
IL236679A0 (en) Preparations and methods for regulating car t cells
SG11201500329WA (en) Stem cell microparticles
SG11201406336YA (en) Stem cell microparticles
SG11201508027PA (en) Methods and compositions for mobilizing stem cells
GB201408236D0 (en) Composition and method
GB201122195D0 (en) Composition and method
EP2831939A4 (fr) Électrode pour dispositifs de stockage d'énergie et son procédé de fabrication
EP2790259A4 (fr) Pile rechargeable et procédé de fabrication de celle-ci
EP2869360A4 (fr) Batterie et procédé de fabrication de cette dernière
GB201214704D0 (en) Stem cell culture method
HK1212733A1 (zh) 富含維生素發酵物的組合物和方法
EP2854562A4 (fr) Composition alimentaire et méthode
EP2844272A4 (fr) Méthodes et compositions pour l'augmentation des érythrocytes
EP2915880A4 (fr) Cellules de type mait et leur méthode de fabrication
EP2704480A4 (fr) Procédé et dispositif permettant de commander une resélection de cellule
EP2823038A4 (fr) Cellules souches placentaires, procédés d'isolation de ces cellules et utilisation de ces procédés
HK1209650A1 (en) Method and composition for metabolic regulation
IL239529B (en) Preparations and methods for creating improved and different cells and organisms
GB201222820D0 (en) Woolscouring method and composition
EP2910778A4 (fr) Moulin à vent et procédé permettant de faire fonctionner ce dernier
GB201106433D0 (en) Composition and method
HK1210436A1 (en) Novel cell compositions and methods
IL231798A0 (en) method and preparation